LAM-X

Light-activated nanofiber materials and the VerdiBlot Western blot membrane for life science and medtech customers

Zlatníky-Hodkovice, CzechiaFounded 2020lamxnano.com Website technologies

Highlights

New on EvolcAdded 2026-10-19

About LAM-X

LAM-X develops nanofiber materials based on polymer and photochemistry research. Its products include VerdiBlot, a universal Western blot membrane for protein analysis, and a patented antimicrobial nanofiber technology that incorporates photosensitizers within polymer nanofibers to generate reactive oxygen species under visible light. The antimicrobial material is validated to ISO 22612 and ISO 20743, with biocompatibility tested to ISO 10993. The company also cites water filtration, agrotech and medical wound care as target areas.

Customers include life science laboratories and companies that want to integrate its light-activated technology into their own product lines. VerdiBlot is sold through a buy-now offer, and the company also offers custom solutions and partnerships.

LAM-X was founded in 2020 and is registered in Zlatníky-Hodkovice, Czech Republic; its founding is also described as taking place in Prague. The underlying technology was developed from 2006 to 2019 in the laboratory of Prof. Jiří Mosinger at Charles University. Two projects were co-financed by the Technology Agency of the Czech Republic, one under the SIGMA programme and one under the TREND programme. Roman Chaloupka is CEO and CTO, and Roberto Fernandez is COO.

Product: VerdiBlot universal Western blot membrane and light-activated antimicrobial nanofiber materials

Public contracts

Contracts LAM-X signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.

Customers

3 contracts with 3 buyers · 11.4M CZK

	Contracts	Value
Česká zemědělská univerzita v Praze	1	11.2M CZK
Generali Česká pojišťovna a.s.	1	99k CZK
Ústav molekulární genetiky AV ČR, v. v. i.	1	80k CZK

Open public tenders for LAM-X →

Latest contracts

27 Aug 2026 for Česká zemědělská univerzita v Praze · Smlouva o účasti na řešení projektu č.QL26010259"Využití nanomateriálů v ochraně zelenin pro snížení pesticidní zátěže" · 11.2M CZK register
23 Apr 2025 for Ústav molekulární genetiky AV ČR, v. v. i. · Externí objednávka LAM-X č. 2538 - Otestování vlastností membrán · 80k CZK register
17 Apr 2025 for Generali Česká pojišťovna a.s. · Pojištění majetku a odpovědnosti · 99k CZK register

Jobs at LAM-X

No open positions listed right now.

Leadership

Roman Chaloupka · CEO & CTO
Source: business register
Roberto Fernandez · COO
Source: company website

More biotech & pharma companies

Lipidica
Lipidica develops a blood-based lipidomic test for early detection of pancreatic cancer, aimed at clinical use
Pardubice, CzechiaBiotech & pharmaFounded 2022
Young company
MAPO pharma
Pharmaceutical distribution to hospitals, biologics treatment centres and pharmacies across the Czech Republic
Olomouc, CzechiaBiotech & pharmaFounded 201417 open jobs
New on Evolc
Medi Pharma Vision
Probiotic and microbiome-analysis company offering gut microbiome tests and custom probiotic capsules in the Czech Republic
Brno, CzechiaBiotech & pharmaFounded 2010
New on Evolc
MEDIS INTERNATIONAL
Contract packaging and quality control laboratory services for pharmaceutical companies in the Czech Republic and abroad
Praha, CzechiaBiotech & pharmaFounded 20078 open jobs
New on Evolc
MendelFOLD
Protein structure prediction and allosteric analysis software for researchers and drug discovery teams
Brno, CzechiaBiotech & pharmaFounded 2024
Young company
MicroCen Trans
Develops and supplies probiotic cultures and ingredients for cosmetics, food producers, and health-product customers
Brno, CzechiaBiotech & pharmaFounded 2018
New on Evolc